abstract |
The present invention provides methods or kits with inflammatory cytokines to pretreat 1-ISCs nto augment their immune modulatory effect, in prevention and treatment of various diseases nsuch as multiple sclerosis, arthritis, lupus, sepsis, hepatitis, cirrhosis, Parkinson's disease, nchronic infections, and GvHD. The present invention relates to novel methods for enhancing nthe immunosuppressive or the immune stimulatory activities of mesenchymal stem cells n(JvfSCs). See Fig. 3. |